Clinical Trial Update: Lansoprazole Preventing Gastroduodenal Stress Ulcerations [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating lansoprazole to prevent gastroduodenal stress ulcers in patients undergoing elective coronary artery bypass graft surgery was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroduodenal Ulcers
• Peptic Ulcer Disease

Drugs mentioned

• Lansoprazole (Lansoprazole)

Snippet

Sponsor: Temple University | Conditions: Patients Undergoing Elective Coronary Artery Bypass Graft | Phase 4 | Status: TERMINATED